Our top pick for
Signature Bank is a banks-regional business based in the US. Signature Bank shares (SBNY) are listed on the NASDAQ and all prices are listed in US Dollars. Signature Bank employs 1,652 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$305.53|
|52-week range||$70.87 - $309.84|
|50-day moving average||$272.66|
|200-day moving average||$250.42|
|Wall St. target price||$321.44|
|Dividend yield||$2.24 (0.74%)|
|Earnings per share (TTM)||$12.70|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||1.86%|
|1 month (2021-09-17)||16.76%|
|3 months (2021-07-16)||29.52%|
|6 months (2021-04-16)||34.26%|
|1 year (2020-10-16)||252.03%|
|2 years (2019-10-17)||152.65%|
|3 years (2018-10-17)||171.29%|
|5 years (2016-10-17)||164.53%|
Valuing Signature Bank stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Signature Bank's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Signature Bank's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Signature Bank shares trade at around 24x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Signature Bank's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.49. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Signature Bank's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Revenue TTM||$1.6 billion|
|Operating margin TTM||60.65%|
|Gross profit TTM||$1.3 billion|
|Return on assets TTM||0.91%|
|Return on equity TTM||12.24%|
|Market capitalisation||$18.5 billion|
TTM: trailing 12 months
There are currently 1.4 million Signature Bank shares held short by investors – that's known as Signature Bank's "short interest". This figure is 19% down from 1.7 million last month.
There are a few different ways that this level of interest in shorting Signature Bank shares can be evaluated.
Signature Bank's "short interest ratio" (SIR) is the quantity of Signature Bank shares currently shorted divided by the average quantity of Signature Bank shares traded daily (recently around 499064.0569395). Signature Bank's SIR currently stands at 2.81. In other words for every 100,000 Signature Bank shares traded daily on the market, roughly 2810 shares are currently held short.
However Signature Bank's short interest can also be evaluated against the total number of Signature Bank shares, or, against the total number of tradable Signature Bank shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Signature Bank's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Signature Bank shares in existence, roughly 20 shares are currently held short) or 0.0239% of the tradable shares (for every 100,000 tradable Signature Bank shares, roughly 24 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Signature Bank.
Find out more about how you can short Signature Bank stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Signature Bank.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 35
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Signature Bank's overall score of 35 (as at 12/31/2018) is pretty weak – landing it in it in the 65th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Signature Bank is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 8.91/100
Signature Bank's environmental score of 8.91 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Signature Bank is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 18.74/100
Signature Bank's social score of 18.74 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Signature Bank is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 18.85/100
Signature Bank's governance score puts it squarely in the 7th percentile of companies rated in the same sector. That could suggest that Signature Bank is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Signature Bank scored a 1 out of 5 for controversy – the highest score possible, reflecting that Signature Bank has managed to keep its nose clean.
|Total ESG score||35|
|Total ESG percentile||64.92|
|Environmental score percentile||7|
|Social score percentile||7|
|Governance score percentile||7|
|Level of controversy||1|
Dividend payout ratio: 17.65% of net profits
Recently Signature Bank has paid out, on average, around 17.65% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.73% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Signature Bank shareholders could enjoy a 0.73% return on their shares, in the form of dividend payments. In Signature Bank's case, that would currently equate to about $2.24 per share.
While Signature Bank's payout ratio might seem low, this can signify that Signature Bank is investing more in its future growth.
Signature Bank's most recent dividend payout was on 12 August 2021. The latest dividend was paid out to all shareholders who bought their shares by 28 July 2021 (the "ex-dividend date").
Over the last 12 months, Signature Bank's shares have ranged in value from as little as $70.874 up to $309.84. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Signature Bank's is 1.9333. This would suggest that Signature Bank's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Signature Bank commercial banking products and services. It accepts various deposit products, including commercial checking accounts, money market accounts, escrow deposit accounts, cash concentration accounts, interest-bearing and non-interest-bearing checking accounts, certificates of deposit, time deposits, and other cash management products. The company also offers loan products comprising commercial and industrial loans; real estate loans; temporary financing for commercial and residential properties; letters of credit; and personal lines of credit and loans to acquire personal assets, as well as asset-based lending, pay check protection loans, main street lending program loans, and credit card accounts. In addition, it provides investment, brokerage, and asset management products and services; retirement products, such as individual retirement accounts and administrative services for retirement vehicles, which include pension, profit sharing, and 401(k) plans to its clients, as well as business retirement accounts; and equipment, transportation, taxi medallion, commercial marine, and municipal and national franchise financing services. Further, the company offers wealth management services to high net worth personal clients; and a range of individual and group insurance products that comprise health, life, disability, and long-term care insurance products as an agent. Additionally, it purchases, securitizes, and sells guaranteed portions of the U. S.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.